Valuation A Complicated Game, Startups, Tech Cos Visualising Future: Thyrocare's Creator, Dr Velumani

Startups and tech companies across industries are being valued today at mountain-high valuations, with investors sprinkling the dry powder and founders aiming for volumes, scale and consolidation and not minding the losses. But the industry today is also not new to certain post-listing debacles of tech companies and a recent valuation turnaround of a health-tech company PharmEasy lowering its valuations by 90 per cent to fund its debt

Kotak Investment Advisors Raises Rs 1,386 Crore For Pre-IPO Fund

The pre-IPO fund will invest in India-focused late-stage new-age businesses with a strong moat of technology, robust unit economics, scalable business models and exit visibility

Pharmeasy To Acquire Thyrocare In Rs 4,546 Crore-Deal

Shares of Thyrocare closed 6.23 per cent up at Rs 1,448.05 apiece on BSE on Friday.

In Every Challenge You Can See An Opportunity, Says Dr. Velumani, Founder, Thyrocare

Dr Velumani, Founder, Thyrocare in conversation with Dr. Annurag Batra, Chairman and Editor-in-Chief, BW Businessworld talks about how India has successfully managed the COVID-19 crisis.

Experts Debate On Quality Vs Cost In Diagnostics Industry And Kind Of Regulation Needed

A panel discussion on ‘Quality vs cost in the diagnostics tests and services and the regulation needed, therefore’ was held at 1st BW Diagnostics Summit, in New Delhi.

Thyrocare Plans Rs 400 Cr IPO By Early Next Year